Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rang in Aktien #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Aktienkurs
$42.98
Zuletzt synchronisiert: 2024-06-21
Marktkapitalisierung
$1.62B
Veränderung (1 Tag)
0.01%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel Taro Pharmaceutical Industries Ltd. (TARO)

Kategorie

Operative Marge für Taro Pharmaceutical Industries Ltd. (TARO)
Operative Marge zum August 2026 TTM: 3.42%
Laut den neuesten Finanzberichten und dem Aktienkurs von Taro Pharmaceutical Industries Ltd. beträgt die aktuelle operative Marge (TTM) 3.42%. Am Ende des Jahres 2023 lag die operative Marge bei 3.09%.
Historie der operativen Marge von Taro Pharmaceutical Industries Ltd. von 1999 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 3.42% 0.00%
2024 3.42% 10.68%
2023 3.09% -90.59%
2022 32.84% -74.41%
2021 128.32% 235.56%
2020 38.24% -13.50%
2019 44.21% -3.43%
2018 45.78% -21.82%
2017 58.56% -9.39%
2016 64.63% 5.71%
2015 61.14% 7.89%
2014 56.67% 15.72%
2013 48.97% 12.32%
2011 43.60% 97.91%
2010 22.03% 24.96%
2009 17.63% 32.46%
2008 13.31% -27.98%
2007 18.48% -166.26%
2006 -27.89% -646.86%
2005 5.10% -2,933.33%
2004 -0.18% -100.76%
2003 23.68% -5.92%
2002 25.17% 15.30%
2001 21.83% 40.75%
2000 15.51% 20.23%
1999 12.90% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -93.30%
IN
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.